Better treatment adherence
More patients in the PMA-zeolite group completed the planned chemotherapy cycles than in the placebo group (p = 0.03) — in 120 patients receiving oxaliplatin-based chemotherapy.
Vitale, M.G. et al.: ZeOxaNMulti Trial. Molecules 2020, 25(10), 2297.
View publication (DOI)
